tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Prakhar Agrawal, 31 are a BUY (91.18%), 3 are a HOLD (8.82%).
Analyst Prakhar Agrawal, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 34.07% that have a potential upside of 37.68% achieved within 78 days.
Prakhar Agrawal’s has documented 66 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AKRO, Akero Therapeutics at 20-Jun-2024.
Analyst best performing recommendations are on NEXI (NEXIMMUNE).
The best stock recommendation documented was for DICE (DICE MOLECULES HOLDINGS LLC) at 9/14/2022. The price target of $36 was fulfilled within 27 days with a profit of $16.39 (83.58%) receiving and performance score of 30.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
100
$0.01 (0.01%)
120
2 years 6 months 22 days ago
3/5 (60%)
$6.56 (7.02%)
256
Hold
100
2 years 8 months 4 days ago
4/6 (66.67%)
$9.27 (10.22%)
204
Hold
100
$0.01 (0.01%)
102
2 years 8 months 16 days ago
4/6 (66.67%)
$7.15 (7.70%)
247
Hold
79
2 years 8 months 16 days ago
5/5 (100%)
$33.14 (72.26%)
401
Hold
100
$0.01 (0.01%)
2 years 8 months 16 days ago
3/4 (75%)
$7.15 (7.70%)
557
Which stock is Prakhar Agrawal is most bullish on?
What Year was the first public recommendation made by Prakhar Agrawal?
